Mesa Science Associates’ Co-Author a Paper on Cyanide Poisoning Presented at the 13th Annual NIH Counter Act Meeting
Mr. Michael Mesa, President and CEO at Mesa Science Associates Inc. (MSA) announced today that MSA was a sponsor and participant at the 13th annual NIH Counter ACT meeting held on June 18-20 at the New York Academy of Sciences. The purpose of the meeting was to discuss the latest research aimed treating threats from chemical and biological agents. The biological threat agents include anthrax, smallpox as well as emerging newer toxins. The chemical threats include vesicants such as mustard and chlorine gases, nerve agents including sarin and VX, and respiratory depressants such as cyanide.
For the last several years MSA has collaborated on a cyanide project with researchers from the University of California and provided a co-investigator for an NIH grant awarded to Dr. Gerry Boss at the University of California, San Diego. The Grant (U01 NS105057), has allowed Dr. Boss to direct his research towards developing new antidotes to cyanide poisoning. In addition to it’s potential as a chemical threat agent, cyanide is also produced in residential and commercial fires and is a lethal component associated with smoke inhalation. MSA Associates, Ken Dretchen PhD, Matt Robben PhD and Michael Mesa were co-authors on a paper demonstrating the results from the past years research. MSA co-authors were listed on the paper and an associated poster by co-authors from the University of Colorado, The University of California Irvine, the University of Colorado and SRI international. The paper, presented by Dr Boss, was entitled “Sodium Tetrathionate as a Cyanide Antidote”. The scientific report demonstrated that the proposed drug is capable of immediately reversing respiratory depression associated with cyanide intoxication in several different animal species and at a dose which should be safe and effective in humans. The results of this study will be the basis of future discussions with the Food and Drug Administration regarding advancing this drug product to the next stage of development.
In addition, Dr. Matt Robben from MSA presented a paper at the meeting entitled “Drug Product Formulations: Planning Efficient Formulation Transition from Discovery to First Human Trials”. The paper was extremely well received as it provided valuable advice to the attendees on how to overcome drug formulation issues associated with transitioning a potential medical countermeasure product from the discovery stage to pre-clinical trials and ultimately to human clinical trials.
Mesa Science Associates Inc is located inside the Frederick Innovation and Technology Center at 4539 Metropolitan Ct. in Frederick Md.
Written By:
Michael Mesa, CEO of Mesa Science Associates Inc. (MSA)
Share this news:
Business Development for Frederick!
For scientists and entrepreneurs who want tough love from proven growth fanatics to confidently take the next step.
Email Sign-Up
Get Connected! Stay up to date on FITCI Activities and Events.
Stay up to date on our newest products and services.
Your information is 100% safe. We hate spam too.
U.S. DEPARTMENT OF COMMERCE ANNOUNCES 51 “BUILD TO SCALE” GRANTS TOTALING $47 MILLIONTO FUEL INNOVATION AND TECH-BASED ECONOMIC DEVELOPMENT
Contact: EDA Public Affairs Department, (202) 482-4085
October 5, 2022
WASHINGTON – Today, U.S. Secretary of Commerce Gina Raimondo announced that the Department’s Economic Development Administration (EDA) is awarding 51 “Build to Scale” grants – totaling $47 million – to organizations that support technology entrepreneurs, catalyze innovation and fuel economic growth.
EDA’s “Build to Scale” program provides annual grants that aim to accelerate technology entrepreneurship by increasing inclusive access to entrepreneurial support and startup capital. The 2022 awardees will leverage an additional $48 million in matching funds from a variety of private and public sector sources. These EDA investments support advanced manufacturing, bioscience, clean energy and blue economy clusters in regions throughout the United States.
"Strengthening technology ecosystems are a critical key to the Biden Administration's efforts to build a stronger America,” said Secretary of Commerce Gina Raimondo. “Innovation and entrepreneurship have long been keys to American success and will continue to strengthen our collective economic and national security, as well as individual prosperity and well-being.”
"EDA is proud to partner with this year's 'Build to Scale' grantees as they invest in entrepreneurs and create equitable access to capital in their communities," said Assistant Secretary of Commerce for Economic Development Alejandra Y. Castillo. "These projects will give the next generation of industry-leading companies a seminal boost that will result in job creation and private investment – potentially transforming a regional economy and creating economic opportunity beyond what we can foresee.”
The 2022 Build to Scale program was comprised of two competitions––the Venture Challenge and the Capital Challenge. The Venture Challenge supports programs that enable high-growth technology entrepreneurship and foster inclusive access to proven entrepreneurship support models. The Capital Challenge increases access to capital in communities where risk capital is in short supply by providing operational support for early-stage investment funds, networks, and training programs that focus on both traditional and hybrid equity-based financing.
About the U.S. Economic Development Administration (www.eda.gov)
The mission of the U.S. Economic Development Administration (EDA) is to lead the federal economic development agenda by promoting competitiveness and preparing the nation's regions for growth and success in the worldwide economy. An agency within the U.S. Department of Commerce, EDA invests in communities and supports regional collaboration in order to create jobs for U.S. workers, promote American innovation, and accelerate long-term sustainable economic growth.
